UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 53

Sortiert nach

Standardized quality (SQ) house dust mite sublingual immunotherapy tablet (ALK) reduces inhaled corticosteroid use while maintaining asthma control: A randomized, double-blind, placebo-controlled trial

Journal of allergy and clinical immunology, 2014-09, Vol.134 (3), p.568-575.e7

2014

Link zum Volltext

Verfügbarkeit prüfen

Long-lasting effects of sublingual immunotherapy according to its duration: A 15-year prospective study

Journal of allergy and clinical immunology, 2010-11, Vol.126 (5), p.969-975

2010

Link zum Volltext

Verfügbarkeit prüfen

Development and validation of the Drug Hypersensitivity Quality of Life Questionnaire

Annals of allergy, asthma, & immunology, 2011-04, Vol.106 (4), p.330-335

2011

Link zum Volltext

Verfügbarkeit prüfen

The possible influence of the environment on respiratory allergy: a survey on immigrants to Italy

Annals of allergy, asthma, & immunology, 2011-05, Vol.106 (5), p.407-411

2011

Link zum Volltext

Verfügbarkeit prüfen

Clinical and cytologic characteristics of allergic rhinitis in elderly patients

Annals of allergy, asthma, & immunology, 2012-03, Vol.108 (3), p.141-144

2012

Link zum Volltext

Verfügbarkeit prüfen

Sublingual immunotherapy for Alternaria -induced allergic rhinitis: a randomized placebo-controlled trial

Annals of allergy, asthma, & immunology, 2010-11, Vol.105 (5), p.382-386

2010

Link zum Volltext

Verfügbarkeit prüfen

Sublingual immunotherapy: focus on tablets

Annals of allergy, asthma, & immunology, 2015-07, Vol.115 (1), p.4-9

2015

Link zum Volltext

Verfügbarkeit prüfen

Efficacy of sublingual immunotherapy in the treatment of allergic rhinitis in pediatric patients 3 to 18 years of age: a meta-analysis of randomized, placebo-controlled, double-blind trials

Annals of Allergy, Asthma & Immunology, 2006-08, Vol.97 (2), p.141-148

2006

Link zum Volltext

Verfügbarkeit prüfen

Sublingual immunotherapy in mite-sensitized children with atopic dermatitis: A randomized, double-blind, placebo-controlled study

Journal of allergy and clinical immunology, 2007-07, Vol.120 (1), p.164-170

2007

Link zum Volltext

Verfügbarkeit prüfen

COVID-19: Unanswered questions on immune response and pathogenesis

Journal of allergy and clinical immunology, 2020-07, Vol.146 (1), p.18-22

2020

Link zum Volltext

Verfügbarkeit prüfen

New insights in allergen avoidance measures for mite and pet sensitized patients. A critical appraisal

Respiratory medicine, 2005-11, Vol.99 (11), p.1363-1376

2005

Link zum Volltext

Verfügbarkeit prüfen

Clinical, functional, and immunologic effects of sublingual immunotherapy in birch pollinosis: A 3-year randomized controlled study

Journal of Allergy and Clinical Immunology, 2005-06, Vol.115 (6), p.1184-1188

2005

Link zum Volltext

Verfügbarkeit prüfen

Perturbations of natural killer cell regulatory functions in respiratory allergic diseases

Journal of allergy and clinical immunology, 2008-02, Vol.121 (2), p.479-485

2008

Link zum Volltext

Verfügbarkeit prüfen

Quantitative assessment of the adherence to sublingual immunotherapy

Journal of allergy and clinical immunology, 2004-06, Vol.113 (6), p.1219-1220

2004

Link zum Volltext

Verfügbarkeit prüfen

Clara cell 16 protein in COPD sputum: A marker of small airways damage?

Respiratory medicine, 2007-10, Vol.101 (10), p.2119-2124

2007

Link zum Volltext

Verfügbarkeit prüfen

Frequency of acute systemic reactions in patients with allergic rhinitis and asthma treated with sublingual immunotherapy

Annals of allergy, asthma, & immunology, 2008-09, Vol.101 (3), p.304-310

2008

Link zum Volltext

Verfügbarkeit prüfen

Clinical and immunologic effects of a rush sublingual immunotherapy to Parietaria species: A double-blind, placebo-controlled trial

Journal of allergy and clinical immunology, 1999-11, Vol.104 (5), p.964-968

1999

Link zum Volltext

Verfügbarkeit prüfen

Absorption and distribution kinetics of the major Parietaria judaica allergen (Par j 1) administered by noninjectable routes in healthy human beings

Journal of allergy and clinical immunology, 1997-07, Vol.100 (1), p.122-129

1997

Link zum Volltext

Verfügbarkeit prüfen

Asthma patients' and physicians’ perspectives on the burden and management of asthma: Post-hoc analysis of APPaRENT 1 and 2 to assess predictors of treatment adherence

Respiratory medicine, 2024-06, Vol.227, p.107637-107637, Article 107637

2024

Link zum Volltext

Verfügbarkeit prüfen

Omalizumab in chronic spontaneous urticaria: Efficacy, safety, predictors of treatment outcome, and time to response

Annals of allergy, asthma, & immunology, 2018-10, Vol.121 (4), p.474-478

2018

Link zum Volltext

Verfügbarkeit prüfen

The relationship between asthma control and quality-of-life impairment due to chronic cough: a real-life study

Annals of allergy, asthma, & immunology, 2008-10, Vol.101 (4), p.370-374

2008

Link zum Volltext

Verfügbarkeit prüfen

Serum cytotoxic T lymphocyte–associated antigen 4 in Hymenoptera venom allergy and its modulation by specific immunotherapy

Journal of allergy and clinical immunology, 2009, Vol.123 (1), p.258-260

2009

Link zum Volltext

Verfügbarkeit prüfen

Proteomics of bronchial biopsies: Galectin-3 as a predictive biomarker of airway remodelling modulation in omalizumab-treated severe asthma patients

Immunology letters, 2014-11, Vol.162 (1), p.2-10

2014

Link zum Volltext

Verfügbarkeit prüfen

The ImmunoCAP ISAC molecular allergology approach in adult multi-sensitized Italian patients with respiratory symptoms

Clinical biochemistry, 2011-08, Vol.44 (12), p.1005-1011

2011

Link zum Volltext

Verfügbarkeit prüfen

Analysis of the drop-out rate in patients receiving mepolizumab for severe asthma in real life

Pulmonary pharmacology & therapeutics, 2019-02, Vol.54, p.87-89

2019

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 53

Suche als RSS-Feed

Aktive Filter

KollektionEBSCOhost Psychology and Behavioral Sciences Collection

KollektionElsevier ScienceDirect Journals Complete

ThemaMale

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(53)
Mit Volltextzugriff
(53)

Publikationsform

Artikel
(53)

Sprache

Englisch
(53)
Japanisch
(9)

Erscheinungsjahr

n.n

Thema

Humans
(53)
Female
(49)
Life Sciences & Biomedicine
(49)
Science & Technology
(49)
Adult
(43)
Immunology
(38)
Allergy
(35)
Biological And Medical Sciences
(32)
Medical Sciences
(31)
Middle Aged
(31)
Adolescent
(27)
Aged
(19)
Allergy And Immunology
(17)
Administration, Sublingual
(15)
Double-Blind Method
(15)
Fundamental And Applied Biological Sciences. Psychology
(13)
Fundamental Immunology
(13)
Immunopathology
(13)
Allergens - Immunology
(12)

14 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Standardized quality (SQ) house dust mite sublingual immunotherapy tablet (ALK) reduces inhaled corticosteroid use while maintaining asthma control: A randomized, double-blind, placebo-controlled trial

Long-lasting effects of sublingual immunotherapy according to its duration: A 15-year prospective study

Development and validation of the Drug Hypersensitivity Quality of Life Questionnaire

The possible influence of the environment on respiratory allergy: a survey on immigrants to Italy

Clinical and cytologic characteristics of allergic rhinitis in elderly patients

Sublingual immunotherapy for Alternaria -induced allergic rhinitis: a randomized placebo-controlled trial

Sublingual immunotherapy: focus on tablets

Efficacy of sublingual immunotherapy in the treatment of allergic rhinitis in pediatric patients 3 to 18 years of age: a meta-analysis of randomized, placebo-controlled, double-blind trials

Sublingual immunotherapy in mite-sensitized children with atopic dermatitis: A randomized, double-blind, placebo-controlled study

COVID-19: Unanswered questions on immune response and pathogenesis

New insights in allergen avoidance measures for mite and pet sensitized patients. A critical appraisal

Clinical, functional, and immunologic effects of sublingual immunotherapy in birch pollinosis: A 3-year randomized controlled study

Perturbations of natural killer cell regulatory functions in respiratory allergic diseases

Quantitative assessment of the adherence to sublingual immunotherapy

Clara cell 16 protein in COPD sputum: A marker of small airways damage?

Frequency of acute systemic reactions in patients with allergic rhinitis and asthma treated with sublingual immunotherapy

Clinical and immunologic effects of a rush sublingual immunotherapy to Parietaria species: A double-blind, placebo-controlled trial

Absorption and distribution kinetics of the major Parietaria judaica allergen (Par j 1) administered by noninjectable routes in healthy human beings

Asthma patients' and physicians’ perspectives on the burden and management of asthma: Post-hoc analysis of APPaRENT 1 and 2 to assess predictors of treatment adherence

Omalizumab in chronic spontaneous urticaria: Efficacy, safety, predictors of treatment outcome, and time to response

The relationship between asthma control and quality-of-life impairment due to chronic cough: a real-life study

Serum cytotoxic T lymphocyte–associated antigen 4 in Hymenoptera venom allergy and its modulation by specific immunotherapy

Proteomics of bronchial biopsies: Galectin-3 as a predictive biomarker of airway remodelling modulation in omalizumab-treated severe asthma patients

The ImmunoCAP ISAC molecular allergology approach in adult multi-sensitized Italian patients with respiratory symptoms

Analysis of the drop-out rate in patients receiving mepolizumab for severe asthma in real life

Aktive Filter

Suchergebnisse filtern